News

Arizona: Increase in Fentanyl Exposure

Arizona Experiencing Increase in Illicit Fentanyl Exposure

Millennium Health Releases Emerging Threat Intelligence™ Report to Help Prevent Opioid Overdoses

SAN DIEGO, Calif. – December 8, 2022 – Millennium Health announced today that illicit fentanyl positivity in Arizona increased by 261% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.Read More

Minnesota: Increase in Fentanyl Exposure

Minnesota Experiencing Increase in Illicit Fentanyl Exposure

Millennium Health Releases Emerging Threat Intelligence™ Report to Help Prevent Opioid Overdoses

SAN DIEGO, Calif. – October 20, 2022 – Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.Read More

Washington: Increase in Fentanyl Use

Washington Experiencing Substantial Increase in Illicit Fentanyl Use for 2022

Millennium Health’s Emerging Threat Intelligence™ Report Finds King and Snohomish Counties Experiencing the Most Significant Increases Statewide

SAN DIEGO, Calif. – September 22, 2022 – A dramatic increase in drug overdose deaths, primarily due to illicit fentanyl, is being reported across the U.S.1 Contributing to these deaths is the proliferation of counterfeit pills often containing fentanyl that are nearly impossible to distinguish from authentic medications.2Read More

PAINWeek 2022 Poster

Millennium Health and Penn State College of Medicine Poster Presented at PAINWeek Regarding Illicit Drug Use Among People with Chronic Pain

SAN DIEGO, Calif. – September 13, 2022 – A study led by Monika Holbein, MD of Penn State College of Medicine and co-authored by Millennium Health researchers, demonstrated that urine specimens from pain management practices tested positive for heroin, illicit fentanyl, cocaine, and methamphetamine more often in patients who were not being prescribed opioids than for those patients who were prescribed opioids. Read More

Journal of Opioid Management Study

Millennium Health Publication in Journal of Opioid Management Provides Encouraging Data on Drug Use Trends in Patients Treated in Pain Management Practices Prescribed Opioids

SAN DIEGO, Calif. – September 7, 2022 – A study published in Journal of Opioid Management, led by Millennium Health researchers and co-authored by Kevin Zacharoff, MD, FACIP, FACPE, FAAP of Stony Brook University, explored the presence of illicit substances in definitive urine drug test (UDT) results in patients prescribed opioids.Read More

UnitedHealthcare Preferred Lab Network

Millennium Health Selected for the UnitedHealthcare Preferred Lab Network

SAN DIEGO, Calif. – August 31, 2022 – Millennium Health is pleased to announce that for the third year in a row, we have been chosen to be a part of the UnitedHealthcare Preferred Lab Network (PLN). Read More

Millennium UDT Update

Expanding Our Novel Psychoactive Substances Test Offerings

SAN DIEGO, Calif. – August 15, 2022 – We are pleased to announce that, as of Monday, August 15, 2022, we are updating our definitive urine drug testing (UDT) menu to expand our novel psychoactive substances test offerings, based on surveillance data from the DEA and Center for Forensic Science Research and Education (CFSRE). Read More

JAMA Study with OSU

Millennium Health and Ohio State University Researchers Work to Save Lives Amid the Substance Use Crisis with Study Published in JAMA Network Open

SAN DIEGO, Calif. – June 8, 2022 – A JAMA Network Open study, led by Millennium Health researchers, and co-authored by Rebecca Jackson, MD and Soledad Fernandez, PhD, of The Ohio State University College of Medicine, demonstrates a strong correlation between urine drug test (UDT) results and drug overdose deaths presenting a new opportunity in the fight against our nation’s substance use crisis.

Read More

NIDA-Funded Research with UC

Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction

SAN DIEGO, Calif. – May 10, 2022 – Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction. 

Read More